Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilad Halpert

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Autoimmunity Reviews|August 26, 2014
The effect of the novel tellurium compound AS101 on autoimmune diseasesGilad Halpert, Benjamin Sredni
Harefuah|September 21, 2020
[SILICONE BREAST IMPLANTS - HISTORICAL MEDICAL ERROR]Gilad Halpert, Howard Amital, Yehuda Shoenfeld
The Israel Medical Association Journal : IMAJ|April 2, 2025
Cannabidiol and Its Effects on Patients with COVID-19 InfectionYuval Kuntzman, Gilad Halpert, Howard Amital
The Israel Medical Association Journal : IMAJ|June 23, 2022
Cannabis and Autoimmune DiseasesShir Rubinstein Levy, Gilad Halpert, Howard Amita
Harefuah|June 17, 2024
[THE MUSCULAR COMPONENT OF FIBROMYALGIA PATHOPHYSIOLOGY]Daniel Yechiali, Liel Katbi, Gilad Halpert, et al.
Journal of Inflammation (London, England)|March 9, 2010
The anti-inflammatory effects of the tellurium redox modulating compound, AS101, are associated with regulation of NFkappaB signaling pathway and nitric oxide induction in macrophagesMiri Brodsky, Gilad Halpert, Michael Albeck, et al.
Autoimmunity Reviews|September 4, 2025
Exploring therapeutic potential of Cannabis based therapy in autoimmune and rheumatic disordersInbar Michaeli, Simon Lassman, Gilad Halpert, et al.
Autoimmunity Reviews|February 21, 2021
The SARS-CoV-2 as an instrumental trigger of autoimmunityArad Dotan, Sylviane Muller, Darja Kanduc, et al.
Clinical Reviews in Allergy & Immunology|July 28, 2023
Shared Pathogenicity Features and Sequences between EBV, SARS-CoV-2, and HLA Class I Molecule-binding Motifs with a Potential Role in AutoimmunityYekbun Adiguzel, Naim Mahroum, Sylviane Muller, et al.
Brain Research|October 5, 2025
Immune-mediated mechanisms of cognitive memory dysfunction: From autoimmune diseases to therapeutic neuromodulationLimor Shtoots, Gilad Halpert, Roni Partouche, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Autoimmunity Reviews|August 26, 2014
The effect of the novel tellurium compound AS101 on autoimmune diseasesGilad Halpert, Benjamin Sredni
Harefuah|September 21, 2020
[SILICONE BREAST IMPLANTS - HISTORICAL MEDICAL ERROR]Gilad Halpert, Howard Amital, Yehuda Shoenfeld
The Israel Medical Association Journal : IMAJ|April 2, 2025
Cannabidiol and Its Effects on Patients with COVID-19 InfectionYuval Kuntzman, Gilad Halpert, Howard Amital
The Israel Medical Association Journal : IMAJ|June 23, 2022
Cannabis and Autoimmune DiseasesShir Rubinstein Levy, Gilad Halpert, Howard Amita
Harefuah|June 17, 2024
[THE MUSCULAR COMPONENT OF FIBROMYALGIA PATHOPHYSIOLOGY]Daniel Yechiali, Liel Katbi, Gilad Halpert, et al.
Journal of Inflammation (London, England)|March 9, 2010
The anti-inflammatory effects of the tellurium redox modulating compound, AS101, are associated with regulation of NFkappaB signaling pathway and nitric oxide induction in macrophagesMiri Brodsky, Gilad Halpert, Michael Albeck, et al.
Autoimmunity Reviews|September 4, 2025
Exploring therapeutic potential of Cannabis based therapy in autoimmune and rheumatic disordersInbar Michaeli, Simon Lassman, Gilad Halpert, et al.
Autoimmunity Reviews|February 21, 2021
The SARS-CoV-2 as an instrumental trigger of autoimmunityArad Dotan, Sylviane Muller, Darja Kanduc, et al.
Clinical Reviews in Allergy & Immunology|July 28, 2023
Shared Pathogenicity Features and Sequences between EBV, SARS-CoV-2, and HLA Class I Molecule-binding Motifs with a Potential Role in AutoimmunityYekbun Adiguzel, Naim Mahroum, Sylviane Muller, et al.
Brain Research|October 5, 2025
Immune-mediated mechanisms of cognitive memory dysfunction: From autoimmune diseases to therapeutic neuromodulationLimor Shtoots, Gilad Halpert, Roni Partouche, et al.
Pageof 5